<VariationArchive VariationID="10907" VariationName="NC_000023.11:g.(?_124346562)_(124346780_124365760)del" VariationType="Deletion" Accession="VCV000010907" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-06" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25946" VariationID="10907">
      <GeneList>
        <Gene Symbol="SH2D1A" FullName="SH2 domain containing 1A" GeneID="4068" HGNC_ID="HGNC:10820" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq25</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="124346563" stop="124373160" display_start="124346563" display_stop="124373160" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="123480131" stop="123507009" display_start="123480131" display_stop="123507009" Strand="+" />
          </Location>
          <OMIM>300490</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SH2D1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SH2D1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.(?_124346562)_(124346780_124365760)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq25</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" innerStart="124346562" innerStop="124346780" outerStop="124365760" display_start="124346562" display_stop="124365760" variantLength="19199" />
      </Location>
      <OtherNameList>
        <Name>EX1DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(?_124346562)_(124346780_124365760)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(?_124346562)_(124346780_124365760)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300490.0010" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.(?_124346562)_(124346780_124365760)del AND X-linked lymphoproliferative disease due to SH2D1A deficiency" Accession="RCV000011654" Version="9">
        <ClassifiedConditionList TraitSetID="3039">
          <ClassifiedCondition DB="MedGen" ID="C5399825">X-linked lymphoproliferative disease due to SH2D1A deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10556288</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10691868</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3039" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5424" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY 5</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY, X-LINKED PROGRESSIVE COMBINED VARIABLE</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFECTIOUS MONONUCLEOSIS, SEVERE, SUSCEPTIBILITY TO</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked lymphoproliferative disease due to SH2D1A deficiency</ElementValue>
                <XRef ID="MONDO:0024551" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lymphoproliferative syndrome 1, X-linked</ElementValue>
                <XRef ID="Lymphoproliferative+syndrome+X-linked+1/4379" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Purtilo syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EBV infection severe susceptibility to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epstein Barr virus infection familial fatal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Duncan's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Duncan disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IMD5</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XLP1</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLPD</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLP</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EBVS</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LYP</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7906" />
                <XRef ID="7906" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked lymphoproliferative disease (XLP) has two recognizable subtypes, XLP1 and XLP2. XLP1 is characterized predominantly by one of three commonly recognized phenotypes: Inappropriate immune response to Epstein-Barr virus (EBV) infection leading to hemophagocytic lymphohistiocytosis (HLH) or severe mononucleosis. Dysgammaglobulinemia. Lymphoproliferative disease (malignant lymphoma). XLP2 is most often characterized by HLH (often associated with EBV), dysgammaglobulinemia, and inflammatory bowel disease. HLH resulting from EBV infection is associated with an unregulated and exaggerated immune response with widespread proliferation of cytotoxic T cells, EBV-infected B cells, and macrophages. Dysgammaglobulinemia is typically hypogammaglobulinemia of one or more immunoglobulin subclasses. The malignant lymphomas are typically B-cell lymphomas, non-Hodgkin type, often extranodal, and in particular involving the intestine.</Attribute>
                <XRef ID="NBK1406" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301580</ID>
                <ID Source="BookShelf">NBK1406</ID>
              </Citation>
              <XRef ID="2442" DB="Orphanet" />
              <XRef ID="538931" DB="Orphanet" />
              <XRef ID="C5399825" DB="MedGen" />
              <XRef ID="MONDO:0024551" DB="MONDO" />
              <XRef Type="MIM" ID="308240" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31886" SubmissionDate="2011-02-09" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300490.0010_LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1" title="SH2D1A, EX1DEL _LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1" />
        <ClinVarAccession Accession="SCV000031886" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 brothers with XLP (308240) who presented with B-cell non-Hodgkin lymphoma without evidence of Epstein-Barr virus infection, Brandau et al. (1999) and Strahm et al. (2000) identified a deletion in the first exon of the SH2D1A gene. The brothers presented at ages 4 and 2 years, respectively.</Attribute>
              <Citation>
                <ID Source="PubMed">10556288</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10691868</ID>
              </Citation>
              <XRef DB="OMIM" ID="308240" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SH2D1A" />
          </GeneList>
          <Name>SH2D1A, EX1DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX1DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300490.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="31886" TraitType="Disease" MappingType="Name" MappingValue="LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1" MappingRef="Preferred">
        <MedGen CUI="C5399825" Name="X-linked lymphoproliferative disease due to SH2D1A deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

